Unyango oluncediswa yi-MDMA ludlulisa uvavanyo olukhulu: iipesenti ezingama-67 zezigulana ze-PTSD zinamava okuncitshiswa

emnyango druginc

Unyango oluncediswa yi-MDMA ludlulisa uvavanyo olukhulu: iipesenti ezingama-67 zezigulana ze-PTSD zinamava okuncitshiswa

Iqela elidumileyo leziyobisi ze-MDMA liyaqhubeka nezifundo zalo ukuya kumajelo oqobo eklinikhi kunye nesiphumo esiphumeleleyo sesigaba sokuqala sophando lwe-psychedelic compound. Isifundo esitsha sibonisa ukuba i-MDMA, eyaziwa ngokuba yi-Ecstasy okanye uMolly, yayisebenza ekuphuculeni iimpawu zoxinzelelo lwasemva koxinzelelo (PTSD). Abaguli bezilingo babe neziphumo ezilungileyo ngokongeza amayeza e-psychoactive kunyango lwengqondo.

Kwilingo elilawulwa ngokungahleliwe labantu abadala abangama-90 abane-PTSD engapheliyo, abo bayibonayo MDMAI-pharmacotherapy kunye nonyango lwengqondo lufezekisile ukuphucuka okubonakalayo kwiimpawu ze-PTSD njengoko kulinganiswa ngugqirha osetyenzisiweyo I-CAPS-5 yaManqaku onke oBunzima kuthelekiswa nabo bafumene kuphela i-placebo kunye nonyango lwengqondo.

Kwafunyaniswa ukuba iipesenti ezingama-67 zabathathi-nxaxheba abanesifo esinganyangekiyo sasemva koxinzelelo babengasakufanelekeli ukuxilongwa emva kweeseshoni zonyango ezincediweyo ze-MDMA. Ngokupheleleyo, iipesenti ezingama-88 zabathathi-nxaxheba bafumana ukunciphisa okukhulu kwiimpawu.

NgoMvulo, uMbutho weeMultidisciplinary Association of Psychedelic Study ukhuphe iziphumo zophononongo lwawo, oluye lwafumanisa ukuba iipesenti ezingama-67 zabathathi-nxaxheba abanesifo esinganyangekiyo emva koxinzelelo abaselungelanga ukuxilongwa emva kweeseshoni zonyango ezincediweyo ze-MDMA.

Ngokupheleleyo, iipesenti ezingama-88 zabathathi-nxaxheba bafumana ukunciphisa okukhulu kwiimpawu.

Abaphandi banethemba lokuba iziphumo ziya kunceda ekufumaneni unyango olubonisiweyo oluvunyiweyo yi-US Food and Drug Administration (FDA) ngowama-2023. Isifundo sesi-3 siphindaphindekile kwaye sandisiwe kwiziphumo zesigaba 2, sibonisa ukuba le ndlela inokuba yonyango olusebenzayo nolungenaxabiso kwi-PTSD ngenxa yaso nasiphi na isizathu.

Kwingxelo, umbhali okhokelayo walatha kwiziphumo zabantu abane-PTSD engafaniyo, abadandathekileyo okanye abanike ingxelo ngembali yotywala okanye yokusebenzisa iziyobisi.

“Abantu abanezona ngxaki zinzima zokunyanga, ekuthiwa zithathwa njengezingenakuphepheka, basabela kakuhle kolu nyango lutsha njengabanye abathathi-nxaxheba. Ngapha koko, abathathi-nxaxheba bafunyaniswe benesicatshulwa esinganyangekiyo se-PTSD bafumana ukuncipha okukhulu kweempawu kunaleyo ingenalo uhlobo olungasasebenziyo. ”

I-MDMA kuthiwa ingunobangela wokunyanga apho kuthiwe into leyo yindlela yonyango yamava efuna ukujonga kakuhle kunye nokuseta ukuze ifumane iziphumo ezilungileyo.

"Ngelixa iindlela ezininzi zonyango lwe-PTSD zibandakanya ukukhumbula ukwenzakala okudlulileyo, kunokwenzeka ukuba ubuchule obukhethekileyo be-MDMA bokuhlakulela uvelwano kunye nokuqonda ngelixa ukunciphisa uxinzelelo kuyivumela ukuba isebenze kangaka."

Ulingo lweSigaba 3 lwenziwa yiNkampani ye-MAPS yoNcedo loLuntu, inkampani exhaswa ngokupheleleyo yi-MAPS egxile ekuqhubeleni phambili kuphando lwe-psychedelic.

Abaphandi bafumana abantu abangama-90 abaphethwe yi-PTSD engapheliyo. Isiqingatha sabathathi-nxaxheba safumana iiseshoni ezintathu ze-MDMA okanye i-placebo, kunye nonyango lokuthetha.

Abathathi-nxaxheba kwisifundo esisekwe kwi-MDMA ngokomndilili bahlupheke kwi-PTSD kangangeminyaka eli-14

Emva konyango, iipesenti ezingama-67 zabantu-abaphethwe yi-PTSD ngokomyinge weminyaka eli-14-babengenazo kwaphela iimpawu, ngelixa iipesenti ezingama-88 zazinempawu ezimbalwa.

Izihloko zophando zibandakanya abantu abane-PTSD ngenxa yemfazwe kunye neziganeko ezinxulumene nokulwa, iingozi kunye nokuxhatshazwa-iipesenti ezingama-84 zabathathi-nxaxheba banembali yokuqaqanjelwa ngumntwana.

Abathathi-nxaxheba kwisifundo esisekwe kwi-MDMA ngokomndilili bahlupheke kwi-PTSD kangangeminyaka eli-14 (fig.)
Abathathi-nxaxheba kwisifundo esisekwe kwi-MDMA bahlupheke kwi-PTSD ngokomyinge weminyaka eli-14 (Ngomhla.)

Ngokwengxelo, i-MDMA khange iwonyuse umngcipheko wokucinga ngokuzibulala okanye indlela yokuziphatha kwaye ayonyusanga umngcipheko wentliziyo xa kuthelekiswa nonyango nge-placebo.

I-MDMA idweliswe yi-FDA njengeshedyuli yeShedyuli I, echazwe njengengenasibonelelo sonyango. Kufikeleleka ngokusemthethweni kuphela kwizifundo zeklinikhi.

"Ngenxa yolu phononongo, nangokusetyenziswa okuqhubekekayo nokungaguquguqukiyo kobungqongqo bezenzululwazi, sibonisile ukuba unyango oluncediswa yi-MDMA kunokwenzeka ukuba lubonelele ngoncedo kubantu abafunyaniswe ukuba bane-PTSD."

Isigaba sesibini solingo lweklinikhi njengangoku lubhalisa abathathi-nxaxheba.

Phambi kokuvunywa okulindelweyo kunyango lwe-PTSD oluncedwayo lwe-MDMA ngo-2023, i-FDA isuse inkqubo yokufikelela eyandisiweyo apho izigulana ezingama-50 zingalufumana khona unyango.

Izicwangciso ze-MAPS zokuqhuba izifundo ezongezelelweyo ukuphanda unyango olunokubakho kwezinye izifo zengqondo, kunye nezinye iinkqubo zonyango ezifana nonyango lweqela kunye nonyango lokuziphatha kwengqondo kwizibini ezitshatileyo.

Imithombo ao MAPS (EN), IMedPageNamhla (EN), muggle intloko (EN), ITheConversation (ENIsayensi (ZMEScience)EN)

Amanqaku afanelekileyo

Shiya iikhomenti

[adrate ibhanile = "89"]